| scholarly article | Q13442814 |
| P2093 | author name string | Yi Li | |
| Hsiang-Fu Kung | |||
| Yi-Dong Wang | |||
| Ying Peng | |||
| Lei He | |||
| Dan Xie | |||
| Jun-Jian Huang | |||
| Xiang-Pen Li | |||
| Han-Xian Gong | |||
| P2860 | cites work | Specific Association of Human Telomerase Activity with Immortal Cells and Cancer | Q27860801 |
| Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells | Q28140743 | ||
| The hTERT promoter enhances the antitumor activity of an oncolytic adenovirus under a hypoxic microenvironment | Q28728396 | ||
| Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells | Q34003618 | ||
| Telomerase and cancer | Q34188981 | ||
| Tumor antigen-specific T helper cells in cancer immunity and immunotherapy | Q34433202 | ||
| Intravascular adenoviral agents in cancer patients: lessons from clinical trials | Q35043094 | ||
| Management of patients with hepatitis B virus-induced cirrhosis | Q36074827 | ||
| Cancer immunotherapy targeting the telomerase reverse transcriptase. | Q36426098 | ||
| A rapid method for accurate DNA measurements in single cells in situ using a simple microfluorimeter and Hoechst 33258 as a quantitative fluorochrome | Q36588957 | ||
| Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus | Q36642484 | ||
| Current treatment strategy for hepatocellular carcinoma. | Q36927996 | ||
| Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model | Q37310677 | ||
| Diepitope multiple antigen peptide of hTERT trigger stronger anti-tumor immune responses in vitro | Q39146626 | ||
| Interleukin-2 gene transfer potentiates the alpha-galactosylceramide-stimulated antitumor effect by the induction of TRAIL in NKT and NK cells in mouse models of subcutaneous and metastatic carcinoma | Q39776994 | ||
| In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells | Q39939752 | ||
| A novel glioblastoma cancer gene therapy using AAV-mediated long-term expression of human TERT C-terminal polypeptide. | Q40154353 | ||
| Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma | Q40275006 | ||
| Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus vector encoding the human erythropoietin gene | Q40961003 | ||
| Current management strategy of hepatocellular carcinoma | Q43093342 | ||
| Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy | Q43648101 | ||
| Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints | Q44203789 | ||
| Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice | Q44260085 | ||
| Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide | Q44735356 | ||
| Type 2 cytotoxic T lymphocytes modulate the activity of dendritic cells toward type 2 immune responses. | Q45861552 | ||
| Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti-apoptotic PI3K/Akt/NF-kappaB pathways | Q46985164 | ||
| Expression of liver phenotypes in cultured mouse hepatoma cells | Q53532544 | ||
| Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies | Q64378032 | ||
| A novel oncolytic adenovirus targeting to telomerase activity in tumor cells with potent | Q64379609 | ||
| Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells | Q74198983 | ||
| Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter | Q82173274 | ||
| P433 | issue | 3 | |
| P921 | main subject | Adenoviridae | Q193447 |
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 748-752 | |
| P577 | publication date | 2013-07-16 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Inhibition of hepatocellular carcinoma growth by adenovirus-mediated expression of human telomerase reverse transcriptase COOH-27 terminal polypeptide in mice | |
| P478 | volume | 6 |
Search more.